The U.S. Food and Drug Administration issued two Emergency Use Authorizations: one for NexGard (afoxolaner) chewable tablets for the treatment of New World screwworm infestations (myiasis) in dogs, and the second for NexGard COMBO (esafoxolaner, eprinomectin, and praziquantel topical solution) for the treatment of NWS myiasis in cats. These EUAs will be effective until they are revoked or the HHS Secretary terminates the declaration that the potential public health emergency presented by NWS justifies the emergency use authorization of animal drugs for NWS.
Source: FDA, February 18, 2026. Link.
Leave a Reply